PharmaCyte Biotech, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 0 | $2.09 | $2.09 | $2.09 |
| Q2 2024 | 0 | $1.58 | $1.58 | $1.58 |
| Q3 2024 | 0 | $1.34 | $1.34 | $1.34 |
| Q4 2024 | 0 | $1.54 | $1.54 | $1.54 |
PharmaCyte Biotech, Inc. Earnings Date And Information
PharmaCyte Biotech, Inc. last posted its earnings results on Wednesday, September 14th, 2022. The company reported $-0.07 earnings per share for the quarter, missing analysts' consensus estimates of $-0.07 by $0. The company had revenue of 0 for the quarter and had revenue of 0 for the year. PharmaCyte Biotech, Inc. has generated $-2 earnings per share over the last year ($-1.8 diluted earnings per share) and currently has a price-to-earnings ratio of 0.63. PharmaCyte Biotech, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, December 13th, 2024 based on prior year's report dates.
PharmaCyte Biotech, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/16/2024 | Q1 2025 | $2.62 | $0 | $0 | ||
| 08/13/2024 | Q4 2024 | -$0.32 | $0 | $0 | ||
| 03/18/2024 | Q3 2024 | -$0.07 | $0 | $0 | ||
| 12/15/2023 | Q2 2024 | -$0.26 | $0 | |||
| 09/18/2023 | Q1 2024 | -$0.25 | $0 | |||
| 07/31/2023 | Q4 2023 | -$0.01 | $0 | |||
| 03/16/2023 | Q3 2023 | $0.00 | $0 | |||
| 12/14/2022 | Q2 2023 | -$0.07 | $0 | |||
| 09/14/2022 | Q1 2023 | -$0.07 | -$0.07 | -0 | $0 | |
| 07/28/2022 | Q4 2022 | -$0.03 | -$0.08 | -0.05 | $0 | |
| 03/15/2022 | Q3 2022 | -$0.05 | -$0.04 | 0.01 | $0 | |
| 12/14/2021 | Q2 2022 | -$0.07 | -$0.06 | 0.01 | $0 | |
| 09/14/2021 | Q1 2022 | -$0.64 | $0 | |||
| 08/10/2021 | Q4 2021 | -$0.62 | $0 | |||
| 03/12/2021 | Q3 2021 | -$0.49 | $0 | |||
| 12/11/2020 | Q2 2021 | -$0.62 | $0 | |||
| 09/11/2020 | Q1 2021 | -$0.79 | $0 | |||
| 08/13/2020 | Q4 2020 | -$0.67 | $0 | |||
| 03/13/2020 | Q3 2020 | -$0.95 | $0 | |||
| 12/23/2019 | Q2 2020 | -$1.21 | $0 |
PharmaCyte Biotech, Inc. Earnings: Frequently Asked Questions
-
When is PharmaCyte Biotech, Inc.'s earnings date?
PharmaCyte Biotech, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, December 13th, 2024 based off last year's report dates.
-
How can I listen to PharmaCyte Biotech, Inc.'s earnings conference call?
The conference call for PharmaCyte Biotech, Inc.'s latest earnings report can be listened to online.
-
How can I read PharmaCyte Biotech, Inc.'s conference call transcript?
The conference call transcript for PharmaCyte Biotech, Inc.'s latest earnings report can be read online.
-
How much profit does PharmaCyte Biotech, Inc. generate each year?
PharmaCyte Biotech, Inc. (:PMCB) has a recorded net income of $0. PharmaCyte Biotech, Inc. has generated $-1.8 earnings per share over the last four quarters.
-
What is PharmaCyte Biotech, Inc.'s price-to-earnings ratio?
PharmaCyte Biotech, Inc. (:PMCB) has a price-to-earnings ratio of 0.63 and price/earnings-to-growth ratio is -0.
